ORAMED PHARM earnings per share and revenue

ORMP earnings per share for the last quarter are -1.79 ILS whereas the estimation was 0.02 ILS which accounts for -9700.00% surprise. Company revenue for the same period amounts to 0.00 ILS despite the estimated figure of 0.00 ILS. Estimated earnings per share for the next quarter are -0.07 ILS, and revenue is expected to reach 0.00 ILS. Also watch annual changes over time to get a bigger picture of ORMP earnings per share and revenue dynamics.